InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Simonian Nancy A, Chairman & CEO. Insider active across 2 companies, notably Seagen Inc.. Cumulatively, 14 disclosures have been published. Split: 0 buy · 2 sells. History available since 14 May 2021. The latest transaction was disclosed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Simonian Nancy A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
37,070 shares@ €0.25629.2% of flowCommon StockSEC:0000950170-24-133338:0
134,713 shares@ €0.253233.1% of flowCommon StockSEC:0000950170-24-131591:0
40,125 sharesCommon StockSEC:0000950170-24-120874:0
4,000 shares0Common StockSEC:0000950170-24-070706:0
6,000 sharesCommon StockSEC:0000950170-24-040308:0
62,753 shares@ US$229.0094.6% of flowCommon StockSEC:0000950170-23-070884:0
40,125 sharesCommon StockSEC:0001209191-23-054174:0
2,044 shares0Common StockSEC:0001203311-23-000059:0
6,000 sharesCommon StockSEC:0001209191-23-022969:0
8,750 shares@ US$36.702.2% of flowCommon StockSEC:0001203311-22-000065:0
1,503 shares0Common StockSEC:0000899243-22-018458:0
58,883 shares@ €1.0115100.0% of flowCommon StockSEC:0001209191-22-022499:0
25,000 shares@ US$20.04100.0% of flowCommon StockSEC:0000899243-22-009424:0
1,402 shares0Common StockSEC:0001203311-21-000036:0
14 of 14 declarations
About Simonian Nancy A
Simonian Nancy A is President and Chief Executive Officer and serves as a director at Syros Pharmaceuticals, Inc. and Seagen Inc. The declarant has 14 filings in total, and in the recent filings tracked, sell volume amounts to EUR 13200684, covering the period from 2021-05-18 to 2024-12-04, with the most frequent transaction nature listed as option exercise.
